Viral Clearance Course of COVID-19 Outbreaks
- PMID: 33707949
- PMCID: PMC7941054
- DOI: 10.2147/JMDH.S302891
Viral Clearance Course of COVID-19 Outbreaks
Abstract
Background: Coronavirus disease 2019 (COVID-19) viral course and behavior remain unpredictable. This study describes incubation time and viral clearance of COVID-19 hospitalized cases in Northern Jordan.
Methods: All COVID-19 confirmed cases hospitalized from March 15 to June 09, 2020, were included. Nasopharyngeal swabs were collected, and COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) was performed every two days in all cases. The viral cure was defined when two negative RT-PCR tests were obtained ≥ 24 hours apart. Viral clearance time (VCT) reflects the time from the first positive nasopharyngeal swab to the first of two consecutive negative tests.
Results: In this cohort, a total of 157 patients were included. Most cases resulted from two major outbreaks. The median incubation period was 6 days (IQR, 3-10) and ranged from 1 to 17 days. The median VCT was 13 days (IQR, 7-2) and ranged from 1 to 40 days. Symptomatic presentation and abnormal chest radiograph were predictors for a prolonged VCT (p=0.015 and p=0.014, respectively). The median time of resolution of symptoms was 7 days (IQR, 3-10 days). Most symptomatic cases (91.7%) remained RT-PCR positive for up to 20 days after symptoms resolution, with a median of 13.5 days. VCT significantly correlated with the incubation period (p=0.013).
Conclusion: Viral cure lagged for as long as 20 days after resolution of symptoms. Continuing with social-distancing, frequent hand hygiene, and wearing facial mask remains essential and is recommended even after clinical resolution of symptoms.
Keywords: CDC; COVID-19; coronavirus; incubation period; pandemic; viral clearance; viral shedding.
© 2021 Samrah et al.
Conflict of interest statement
The authors declare that they have no competing interests in this work.
Figures




Similar articles
-
Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.Chin Med J (Engl). 2020 May 5;133(9):1039-1043. doi: 10.1097/CM9.0000000000000774. Chin Med J (Engl). 2020. PMID: 32118639 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19.Int J Infect Dis. 2021 Apr;105:463-469. doi: 10.1016/j.ijid.2021.02.089. Epub 2021 Feb 27. Int J Infect Dis. 2021. PMID: 33647508 Free PMC article.
-
Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19.Int J Infect Dis. 2020 Oct;99:279-285. doi: 10.1016/j.ijid.2020.07.070. Epub 2020 Aug 5. Int J Infect Dis. 2020. PMID: 32763446 Free PMC article.
-
Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data.Pediatr Infect Dis J. 2020 Sep;39(9):e249-e256. doi: 10.1097/INF.0000000000002814. Pediatr Infect Dis J. 2020. PMID: 32618932
Cited by
-
Enhanced Treatment in Severe-Critical COVID-19 With Tocilizumab, Remdesivir, Dexamethasone: A Jordanian Cohort Study.Cureus. 2024 Aug 22;16(8):e67467. doi: 10.7759/cureus.67467. eCollection 2024 Aug. Cureus. 2024. PMID: 39314607 Free PMC article.
-
The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study.Saudi Pharm J. 2023 Jul;31(7):1210-1218. doi: 10.1016/j.jsps.2023.05.006. Epub 2023 May 23. Saudi Pharm J. 2023. PMID: 37256102 Free PMC article.
-
SARS-CoV-2 Seroepidemiological Investigation in Jordan: Seroprevalence, Herd Immunity, and Vaccination Coverage. A Population-Based National Study.Int J Gen Med. 2022 Sep 5;15:7053-7062. doi: 10.2147/IJGM.S371711. eCollection 2022. Int J Gen Med. 2022. PMID: 36090704 Free PMC article.
-
A Model for Predicting the Duration of Viral Shedding in Patients Who Had Been Hospitalized with Mild COVID-19: A Single-Center Retrospective Study.Infect Drug Resist. 2023 Sep 5;16:5799-5813. doi: 10.2147/IDR.S421938. eCollection 2023. Infect Drug Resist. 2023. PMID: 37692465 Free PMC article.
-
Self-Reported Obsession Toward COVID-19 Preventive Measures Among Undergraduate Medical Students During the Early Phase of Pandemic in Jordan.Front Public Health. 2021 Nov 8;9:719668. doi: 10.3389/fpubh.2021.719668. eCollection 2021. Front Public Health. 2021. PMID: 34820347 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources